TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.100nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair